The outbreak of the Ebola virus disease occurring in West Africa may have originated from contact between humans and virus-infected bats, suggests a study led by researchers from the Robert Koch-Institute. The opensource study, published in EMBO Molecular Medicine, identifies insectivorous free-tailed bats as plausible reservoirs and expands the range of possible Ebola virus sources to this type of bats. The results, based on DNA testing, also reveal that larger wildlife are not the source of infection.
Ebola virus disease epidemics are of zoonotic origin, transmitted to human populations either through contact with larger wildlife or by direct contact with bats. The team monitored the large mammal populations close to the index village Meliandou in south-eastern Guinea and found no evidence for a concurrent outbreak. The second infection route appears more plausible as direct contact with bats is usual in the affected region.
Fruit bats are the commonly suspected Ebola virus reservoir as previous outbreaks in Africa show. Interviews with Meliandou locals revealed that exposure to fruit bats through hunting and consumption of meat in this area is common. Yet fruit bats seem an unlikely source of infection, as a food-borne transmission would have affected adults before or concurrently with the two-year-old boy, the index case. This suggests a source of infection unrelated to food. All bat species mentioned in this study were subject to RNA testing for the Ebola virus.
Another opportunity for infection was a large colony of free-tailed insectivorous bats housed in a hollow tree nearby the home of the index case. Villagers reported that children often used to play in and around the tree. This may have resulted in a massive exposure to bats.
The multidisciplinary team of researchers led a four-week field mission in Guinea in April 2014 to examine human exposure to bats, to survey local wildlife and to capture and sample bats in Meliandou and in neighbouring forests. The index village is not located in the forest but rather in an area heavily modified by humans representing ‘modern’ African settings.
The virus that spread from Meliandou into other areas of Guinea and Sierra Leone, Liberia, Nigeria and Senegal, represents the largest ever-recorded Ebola outbreak killing 7,800 people (as of 17 December 2014).
Source: EMBO Press
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.